Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex.

Bhave VS, Mars W, Donthamsetty S, Zhang X, Tan L, Luo J, Bowen WC, Michalopoulos GK.

Am J Pathol. 2013 Jul;183(1):153-9. doi: 10.1016/j.ajpath.2013.03.013. Epub 2013 May 8.

2.

Glypican-3: a new target for cancer immunotherapy.

Ho M, Kim H.

Eur J Cancer. 2011 Feb;47(3):333-8. doi: 10.1016/j.ejca.2010.10.024. Epub 2010 Nov 26. Review.

3.

Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.

Filmus J, Capurro M.

FEBS J. 2013 May;280(10):2471-6. doi: 10.1111/febs.12126. Epub 2013 Jan 31. Review.

4.

The role of glypicans in Hedgehog signaling.

Filmus J, Capurro M.

Matrix Biol. 2014 Apr;35:248-52. doi: 10.1016/j.matbio.2013.12.007. Epub 2014 Jan 8. Review.

5.

Glypican-mediated endocytosis of Hedgehog has opposite effects in flies and mice.

Beckett K, Franch-Marro X, Vincent JP.

Trends Cell Biol. 2008 Aug;18(8):360-3. doi: 10.1016/j.tcb.2008.06.001. Epub 2008 Jul 5. Review.

PMID:
18603427
6.

Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.

Kandil DH, Cooper K.

Adv Anat Pathol. 2009 Mar;16(2):125-9. doi: 10.1097/PAP.0b013e3181992455. Review.

PMID:
19550373
7.

CD81 as a tumor target.

Vences-Catalán F, Duault C, Kuo CC, Rajapaksa R, Levy R, Levy S.

Biochem Soc Trans. 2017 Apr 15;45(2):531-535. doi: 10.1042/BST20160478. Review.

PMID:
28408492
8.

Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion.

Gaston K, Tsitsilianos MA, Wadey K, Jayaraman PS.

Cell Biosci. 2016 Feb 13;6:12. doi: 10.1186/s13578-016-0077-7. eCollection 2016. Review.

Supplemental Content

Support Center